Published in J Am Chem Soc on May 24, 2006
2-Ethyl-imidazolium terephthalate. Acta Crystallogr Sect E Struct Rep Online (2011) 1.29
(E)-2-[2-(2-Thien-yl)vin-yl]-1H-1,3-benzimidazole. Acta Crystallogr Sect E Struct Rep Online (2008) 1.21
Metal-organic frameworks as a tunable platform for designing functional molecular materials. J Am Chem Soc (2013) 1.13
Piperazine-1,4-diium naphthalene-1,5-disulfonate. Acta Crystallogr Sect E Struct Rep Online (2011) 1.12
Ammonium imidazolium dichromate. Acta Crystallogr Sect E Struct Rep Online (2012) 1.06
Bis(2-ethyl-1H-imidazol-3-ium) tetra-chloridocuprate(II). Acta Crystallogr Sect E Struct Rep Online (2010) 1.06
Bis(2-methyl-piperidinium) penta-chlorido-anti-monate(III). Acta Crystallogr Sect E Struct Rep Online (2012) 1.04
Bis(diisopropyl-ammonium) naphthalene-1,5-disulfonate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.92
Bis(trimethyl-ammonium) naphthalene-1,5-disulfonate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.92
Tetra-aqua-bis-(2-methyl-1H-imidazole-κN)cobalt(II) naphthalene-1,5-disulfonate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.91
1-Cyano-methyl-1,4-diazo-niabicyclo-[2.2.2]octane tetra-bromidocadmate(II). Acta Crystallogr Sect E Struct Rep Online (2010) 0.87
1H-Pyrazol-2-ium hydrogen oxalate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.86
catena-Poly[[bis-(1-ethyl-1H-imidazole-κN)copper(II)]-μ-oxalato-κO,O:O,O]. Acta Crystallogr Sect E Struct Rep Online (2011) 0.84
Dimeth-yl(4-methyl-phen-yl)ammonium naphthalene-1,5-disulfonate dihydrate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.80
Bis(3-hy-droxy-propanaminium) naphthalene-1,5-disulfonate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Integration of metal-organic frameworks into an electrochemical dielectric thin film for electronic applications. Nat Commun (2016) 0.75
1-Chloro-methyl-1,4-diazo-niabicyclo-[2.2.2]octane bis-(hexa-fluoro-phosphate). Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
catena-Poly[2-methyl-1H-imidazol-3-ium [(aqua-chloridocadmate)-di-μ-chlorido]]. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Bis(2,4,6-trimethyl-anilinium) sulfate monohydrate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Bis(pyridinium) naphthalene-1,5-di-sulfonate dihydrate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
4-Chloro-anilinium perchlorate-18-crown-16 (1/1). Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Bis(μ-nitrito-κ(2)O:O)bis-[bis-(1-methyl-1H-imidazole-κN(3))(nitrito-κO)copper(II)]. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
Tetra-kis(4-chloro-anilinium) hexa-chlorido-stannate(IV) dichloride. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
2-{4-[(Quinolin-8-yl-oxy)meth-yl]phen-yl}benzonitrile. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
catena-Poly[tris(2,4,6-trimethyl-anilinium) [(tetrachloridocadmium)-μ-chlorido]]. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Cyclo-hexyl-ammonium 4-meth-oxy-benzoate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Ethyl 2-(4-nitro-phen-oxy)acetate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
Bis(2-methyl-piperidinium) naphthalene-1,5-disulfonate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
Poly[(μ(4)-tetra-zole-1-acetato-κN:N:O:O')silver(I)]. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
2-Ethyl-1H-imidazol-3-ium hemioxalate oxalic acid monohydrate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Guanidinium chloride-18-crown-6 (2/1). Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
2-Chloro-anilinium perchlorate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
Bis-(guanidinium) naphthalene-1,5-di-sulfonate-18-crown-6 (1/1). Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
Bis[(2S,4S)-4-(2-hy-droxy-eth-yl)-2-methyl-piperazine-1,4-diium] di-μ-chlorido-bis-[trichloridocadmium(II)]. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Dichloridotris(2-methyl-1H-imidazole-κN(3))cadmium. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
3-Methyl-piperidinium bromide. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
2,4,6-Trimethyl-anilinium chloro-acetate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
4,4'-(1,3,4-Oxadiazole-2,5-diyl)di-pyri-dinium dibromide monohydrate. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
catena-Poly[[bis-(1H-imidazole-κN)copper(II)]-μ-benzene-1,4-dicarboxyl-ato-κO:O]. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
N-(2-Hy-droxy-benz-yl)adamantan-1-aminium bromide. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Bis[5-(2-amino-3-pyrid-yl)tetra-zolato]copper(II). Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
Guanidinium bromide-18-crown-6 (2/1). Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
(1H-Benzimidazol-2-yl)methanaminium perchlorate-18-crown-6-water (1/1/1). Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Tris(2-methyl-piperidinium) tetra-chlorido-ferrate dichloride. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
1,4-Dimethyl-piperazine-1,4-diium bis-(hexa-fluoro-phosphate) dihydrate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
N-(2-Hy-droxy-benz-yl)adamantan-1-aminium chloride. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Di-μ-nitrito-κO:O-bis-[bis-(1-ethyl-1H-imidazole-κN)(nitrito-κO)copper(II)]. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
4-[(4-Methyl-anilino)meth-yl]benzonitrile. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Aqua-bis-(1-methyl-1H-imidazole-κN)bis-(nitrato-κO)copper(II). Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
4-[5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-yl]pyridinium benzoate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
2-Methyl-piperidinium bromide. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
Bis(2-hy-droxy-ethanaminium) terephthalate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
Bis(2-ethyl-1H-imidazole-κN)bis-(nitrito-κO,O')copper(II) dihydrate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
2,4,6-Trimethyl-anilinium 2-carb-oxy-ethano-ate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Dielectric anisotropy of a homochiral trinuclear nickel(II) complex. J Am Chem Soc (2007) 12.48
New ferroelectrics based on divalent metal ion alum. J Am Chem Soc (2009) 11.12
Discovery of new ferroelectrics: [H2dbco]2 x [Cl3] x [CuCl3(H2O)2] x H2O (dbco = 1,4-Diaza-bicyclo[2.2.2]octane). J Am Chem Soc (2010) 9.80
The first metal-organic framework (MOF) of Imazethapyr and its SHG, piezoelectric and ferroelectric properties. Dalton Trans (2008) 8.86
In situ hydrothermal synthesis of tetrazole coordination polymers with interesting physical properties. Chem Soc Rev (2007) 8.56
3D framework containing Cu4Br4 cubane as connecting node with strong ferroelectricity. J Am Chem Soc (2008) 8.49
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol (2006) 6.93
Syntheses, crystal structures, and luminescent properties of three novel zinc coordination polymers with tetrazolyl ligands. Inorg Chem (2005) 6.71
Hydrogen-bonded ferroelectrics based on metal-organic coordination. J Am Chem Soc (2009) 6.69
Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett (2006) 5.63
Supramolecular bola-like ferroelectric: 4-methoxyanilinium tetrafluoroborate-18-crown-6. J Am Chem Soc (2011) 4.73
Diisopropylammonium chloride: a ferroelectric organic salt with a high phase transition temperature and practical utilization level of spontaneous polarization. Adv Mater (2011) 4.30
Synthesis of novel chiral and acentric coordination polymers by the reaction of zinc or cadmium salts with racemic 3-pyridyl-3-aminopropionic acid. Chemistry (2004) 3.49
Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res (2008) 3.47
US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology (2008) 3.15
Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc Natl Acad Sci U S A (2005) 3.03
A multiferroic perdeutero metal-organic framework. Angew Chem Int Ed Engl (2011) 2.88
Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med (2007) 2.86
Multiferroic homochiral metal-organic framework. Inorg Chem (2008) 2.78
Decoy state quantum key distribution. Phys Rev Lett (2005) 2.77
PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med (2008) 2.77
Highly stable olefin-Cu(I) coordination oligomers and polymers. Chem Soc Rev (2005) 2.72
(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. J Nucl Med (2007) 2.50
2-{4-[5-(3-Pyrid-yl)-2H-tetra-zol-2-ylmeth-yl]phen-yl}benzonitrile. Acta Crystallogr Sect E Struct Rep Online (2008) 2.43
Paused Pol II coordinates tissue morphogenesis in the Drosophila embryo. Cell (2013) 2.42
Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer (2004) 2.32
PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials (2010) 2.31
Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. Eur J Nucl Med Mol Imaging (2007) 2.31
Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators. J Biol Chem (2006) 2.31
PET of vascular endothelial growth factor receptor expression. J Nucl Med (2006) 2.18
Dibromido[(S)-2-(pyrrolidin-2-yl)-1H-benzimidazole]zinc(II). Acta Crystallogr Sect E Struct Rep Online (2008) 2.17
The nanostructured origin of deformation twinning. Nano Lett (2012) 2.13
Bis(nitrato-κO)[(S)-2-(pyrrolidin-2-yl)-1H-benzimidazole]cadmium(II). Acta Crystallogr Sect E Struct Rep Online (2008) 2.12
Large anisotropy and effect of deuteration on permittivity in an olefin copper(I) complex. Angew Chem Int Ed Engl (2007) 2.12
Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab (2010) 2.09
In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3. Cancer Res (2006) 2.09
Ferroelectric metal-organic frameworks. Chem Rev (2011) 2.02
Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem (2001) 1.99
Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation (2011) 1.95
Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol (2005) 1.93
(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression. Eur J Nucl Med Mol Imaging (2008) 1.91
18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression. Mol Imaging Biol (2009) 1.90
Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. J Am Chem Soc (2008) 1.89
A dedicated superbend x-ray microdiffraction beamline for materials, geo-, and environmental sciences at the advanced light source. Rev Sci Instrum (2009) 1.82
Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis (2005) 1.77
Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3. Circ Res (2004) 1.69
NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation (2011) 1.68
Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression. Bioconjug Chem (2007) 1.64
Diisopropylammonium bromide is a high-temperature molecular ferroelectric crystal. Science (2013) 1.61
(±)-5-Ethyl-2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)nicotinic acid. Acta Crystallogr Sect E Struct Rep Online (2008) 1.57
Hydrothermal preparation of novel Cd(II) coordination polymers employing 5-(4-pyridyl)tetrazolate as a bridging ligand. Inorg Chem (2002) 1.54
Scientometric trends and knowledge maps of global health systems research. Health Res Policy Syst (2014) 1.51
Liquid-liquid separation in solutions of normal and sickle cell hemoglobin. Proc Natl Acad Sci U S A (2002) 1.50
Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation (2008) 1.50
Uncoupling protein 2 impacts endothelial phenotype via p53-mediated control of mitochondrial dynamics. Circ Res (2013) 1.48
Two chiral coordination polymers: preparation and X-ray structures of mono(4-sulfo-L-phenylalanine)(diaqua) zinc(II) and copper(II) complexes. Inorg Chem (2002) 1.47
Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano (2010) 1.46
microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4). J Nucl Med (2007) 1.46
Homochiral Zn and Cd coordination polymers containing amino acid-tetrazole ligands. Inorg Chem (2003) 1.46
RNA interference-mediated downregulation of hypoxia-inducible factor-1α inhibits angiogenesis and survival of oral squamous cell carcinoma in vitro and in vivo. Eur J Cancer Prev (2012) 1.45
A new PET tracer specific for vascular endothelial growth factor receptor 2. Eur J Nucl Med Mol Imaging (2007) 1.43
Mechanics and dynamics of the strain-induced M1-M2 structural phase transition in individual VO₂ nanowires. Nano Lett (2011) 1.42
Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. Small (2010) 1.38
Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic Biol Med (2005) 1.36
Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. J Clin Invest (2013) 1.36
Hedgehog signaling is activated in subsets of esophageal cancers. Int J Cancer (2006) 1.34
Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine (2002) 1.30
(S)-2-Ammonio-3-(4-nitro-phen-yl)propanoate monohydrate. Acta Crystallogr Sect E Struct Rep Online (2008) 1.29
18F-labeled BBN-RGD heterodimer for prostate cancer imaging. J Nucl Med (2008) 1.29
Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation. Cancer Res (2009) 1.28
Reversible phase transition of pyridinium-3-carboxylic acid perchlorate. Acta Crystallogr B (2010) 1.26
Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice. Eur J Nucl Med Mol Imaging (2007) 1.26
Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. J Nucl Med (2007) 1.26
Poised RNA polymerase II changes over developmental time and prepares genes for future expression. Cell Rep (2012) 1.25
In vivo tumor-targeted fluorescence imaging using near-infrared non-cadmium quantum dots. Bioconjug Chem (2010) 1.24
Coexistence of magnetic and electric orderings in the metal-formate frameworks of [NH4][M(HCOO)3]. J Am Chem Soc (2011) 1.24
Distribution of tick-borne diseases in China. Parasit Vectors (2013) 1.20
Human serum albumin coated iron oxide nanoparticles for efficient cell labeling. Chem Commun (Camb) (2009) 1.20
Coordination-driven self-assembly of metallodendrimers possessing well-defined and controllable cavities as cores. J Am Chem Soc (2007) 1.18
Noncentrosymmetric organic solids with very strong harmonic generation response. Chemistry (2004) 1.18
Nitroalkenes suppress lipopolysaccharide-induced signal transducer and activator of transcription signaling in macrophages: a critical role of mitogen-activated protein kinase phosphatase 1. Endocrinology (2008) 1.16